AYTU
Aytu Biopharma, IncCompany with tickers: AYTU
CIK
1385818
CUSIP
054754858
Shares Outstanding
10,733,208
13F Activity (30d)
31 filings
31 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $41,464,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | $26,409,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $33,947,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $0 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-7,538,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-14,237,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-1.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-1.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |